These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18686944)

  • 41. Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection.
    Tetko IV; Sushko I; Pandey AK; Zhu H; Tropsha A; Papa E; Oberg T; Todeschini R; Fourches D; Varnek A
    J Chem Inf Model; 2008 Sep; 48(9):1733-46. PubMed ID: 18729318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-HIV agents.
    Chen KX; Xie HY; Li ZG; Gao JR
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5381-6. PubMed ID: 18835162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small-molecule interferon inducers. Toward the comprehension of the molecular determinants through ligand-based approaches.
    Musmuca I; Simeoni S; Caroli A; Ragno R
    J Chem Inf Model; 2009 Jul; 49(7):1777-86. PubMed ID: 19499914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 'Dynamic' QSAR for semicarbazide-induced mortality in frog embryos.
    Mekenyan OG; Schultz TW; Veith GD; Kamenska V
    J Appl Toxicol; 1996; 16(4):355-63. PubMed ID: 8854223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soft quaternary anticholinergics: comprehensive quantitative structure-activity relationship (QSAR) with a linearized biexponential (LinBiExp) model.
    Buchwald P; Bodor N
    J Med Chem; 2006 Feb; 49(3):883-91. PubMed ID: 16451054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploration of the topology of chemical spaces with network measures.
    Krein MP; Sukumar N
    J Phys Chem A; 2011 Nov; 115(45):12905-18. PubMed ID: 21882847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Representation of multi-target activity landscapes through target pair-based compound encoding in self-organizing maps.
    Iyer P; Bajorath J
    Chem Biol Drug Des; 2011 Nov; 78(5):778-86. PubMed ID: 21895984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
    Vaidya M; Weigt M; Wiese M
    Eur J Med Chem; 2009 Oct; 44(10):4070-82. PubMed ID: 19515462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors.
    Falchi F; Manetti F; Carraro F; Naldini A; Maga G; Crespan E; Schenone S; Bruno O; Brullo C; Botta M
    ChemMedChem; 2009 Jun; 4(6):976-87. PubMed ID: 19326384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-activity models of chemical carcinogens: state of the art, and new directions.
    Benigni R; Bossa C
    Ann Ist Super Sanita; 2006; 42(2):118-26. PubMed ID: 17033131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative structure-activity relationship models for predicting biological properties, developed by combining structure- and ligand-based approaches: an application to the human ether-a-go-go-related gene potassium channel inhibition.
    Coi A; Massarelli I; Saraceno M; Carli N; Testai L; Calderone V; Bianucci AM
    Chem Biol Drug Des; 2009 Oct; 74(4):416-33. PubMed ID: 19751420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modelling Structure Activity Landscapes with Cliffs: a Kernel Regression-Based Approach.
    Tebby C; Mombelli E
    Mol Inform; 2013 Jul; 32(7):609-23. PubMed ID: 27481769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Virtual screening for R-groups, including predicted pIC50 contributions, within large structural databases, using Topomer CoMFA.
    Cramer RD; Cruz P; Stahl G; Curtiss WC; Campbell B; Masek BB; Soltanshahi F
    J Chem Inf Model; 2008 Nov; 48(11):2180-95. PubMed ID: 18956863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Robust cross-validation of linear regression QSAR models.
    Konovalov DA; Llewellyn LE; Vander Heyden Y; Coomans D
    J Chem Inf Model; 2008 Oct; 48(10):2081-94. PubMed ID: 18826208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding orientations, QSAR, and molecular design of thiophene derivative inhibitors.
    Liao SY; Chen TJ; Miao TF; Qian L; Zheng KC
    Chem Biol Drug Des; 2009 Sep; 74(3):289-96. PubMed ID: 19703031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies.
    Nayana RS; Bommisetty SK; Singh K; Bairy SK; Nunna S; Pramod A; Muttineni R
    J Chem Inf Model; 2009 Jan; 49(1):53-67. PubMed ID: 19119997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural interpretation of activity cliffs revealed by systematic analysis of structure-activity relationships in analog series.
    Sisay MT; Peltason L; Bajorath J
    J Chem Inf Model; 2009 Oct; 49(10):2179-89. PubMed ID: 19761254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and validation of a pharmacophore-based QSAR model for the prediction of CNS activity.
    Gozalbes R; Barbosa F; Nicolaï E; Horvath D; Froloff N
    ChemMedChem; 2009 Feb; 4(2):204-9. PubMed ID: 19097128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A segmented principal component analysis-regression approach to quantitative structure-activity relationship modeling.
    Hemmateenejad B; Elyasi M
    Anal Chim Acta; 2009 Jul; 646(1-2):30-8. PubMed ID: 19523553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploiting QSAR models in lead optimization.
    Gedeck P; Lewis RA
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):569-75. PubMed ID: 18600573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.